- Category
- Micro (2020-21)
- Udyam number
- UDYAM-HR-03-0009214

Vonmark Pharmaceuticals Private Limited
About Vonmark Pharmaceuticals Private Limited
Data last updated:
Vonmark Pharmaceuticals Private Limited is a private limited company based in Faridabad, Haryana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 04 December 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U74999HR2020PTC091382. Its GSTIN is 10AAHCV7777R1ZG (Bihar).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Rozy Kumari and Ruby Kumari.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Lower Ground Floor Shop No. 17 Sector – 55 T Point Sohna Road, Faridabad, Haryana, India – 121001.
As per the financials filed for FY 2024, the company reported a revenue of ₹49.31 Lakh, a growth of 18% compared to the previous year. For the same year it recorded a net profit of ₹86,383 (net margin 1.8%) and EBITDA of ₹1.2 Lakh (EBITDA margin 2.4%).
As per MCA filings, the company has open charges of ₹10 Lakh on record.
Vonmark Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-03-0009214).
Company details
Recognitions & Rankings of Vonmark Pharmaceuticals
Contact details
Vonmark Pharmaceuticals Private Limited's registered office is in Faridabad, Haryana. Its e-mail address is in the company report.
- Email
- Registered AddressLower Ground Floor Shop No. 17 Sector – 55 T Point Sohna Road, Faridabad, Haryana, India – 121001
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Vonmark Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Vonmark Pharmaceuticals is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Vonmark Pharmaceuticals Private Limited, buy the company report.
Financials of Vonmark Pharmaceuticals Private Limited
FY 2025 filings availableVonmark Pharmaceuticals Private Limited reported revenue of ₹49.31 Lakh (up 18% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 18% in the latest year. EBITDA rose 2% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹1.2 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹86,383 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 2.4% | |||
| Net Profit Margin | 1.8% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Vonmark Pharmaceuticals Private Limited, buy the company report.
Board of directors of Vonmark Pharmaceuticals Private Limited
Vonmark Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rozy Kumari | Director | 04 Dec 2020 | 5 Years 11 Months | Current |
| Ruby Kumari | Director | 04 Dec 2020 | 5 Years 11 Months | Current |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 20 Jan 2025 | 101043533 | Others | ₹10 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Vonmark Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Vonmark Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Vonmark Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAHCV7777R1ZG | Bihar | Active | 12 Jan 2021 |
To see the full GST registrations and return filing status of Vonmark Pharmaceuticals Private Limited, buy the company report.
Recent activity
Vonmark Pharmaceuticals Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Rozy Kumari was appointed as Director on 04 Dec 2020.
Frequently asked questions
Vonmark Pharmaceuticals is an active private limited company based in Faridabad, Haryana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 04 December 2020 (6+ years old) and is registered under CIN U74999HR2020PTC091382.
Vonmark Pharmaceuticals has 2 current directors:
- Rozy Kumari - Director
- Ruby Kumari - Director
The latest financial statements of Vonmark Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Vonmark Pharmaceuticals is 10AAHCV7777R1ZG, registered in Bihar.
The CIN (Corporate Identification Number) of Vonmark Pharmaceuticals is U74999HR2020PTC091382. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Vonmark Pharmaceuticals was incorporated on 04 December 2020, making it 6+ years old. It is registered with the Registrar of Companies, Haryana.
Rozy Kumari was appointed as Director on 04 Dec 2020. Ruby Kumari was appointed as Director on 04 Dec 2020.
Yes, Vonmark Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-HR-03-0009214).
The registered office of Vonmark Pharmaceuticals is at Lower Ground Floor Shop No. 17 Sector – 55 T Point Sohna Road, Faridabad, Haryana, India – 121001.
Vonmark Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

